NCT04650308

Brief Summary

One's appetite has a role in controlling food intake and maintaining energy balance, but its effect on body metabolism related to obesity is still questionable. The purpose of this study was to determine the levels of neuropeptide Y in healthy people and to see differences in gender and anthropometric parameters. The hypothesis of this study was that there would be differences in neuropeptide Y levels in groups with gender and anthropometric parameter differences.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 2, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 23, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 2, 2020

Completed
Last Updated

December 2, 2020

Status Verified

November 1, 2020

Enrollment Period

3 months

First QC Date

November 23, 2020

Last Update Submit

November 30, 2020

Conditions

Nutrient Deficiency

Keywords

obesityappetiteneuropeptideorexigenicenergygender

Outcome Measures

Primary Outcomes (1)

  • levels of neuropeptide Y

    up to 2 weeks

Study Arms (2)

Healthy group

ACTIVE COMPARATOR

healthy men and women aged 20-60 years old.

Diagnostic Test: Neuropeptide Y examination

Non-healthy group

ACTIVE COMPARATOR

pregnant women, nursing mothers, impaired kidney and liver function, chronic disease, or other metabolic disorders.

Diagnostic Test: Neuropeptide Y examination

Interventions

Neuropeptide Y examinationDIAGNOSTIC_TEST

This examination was conducted by drawing blood serum from research subjects and performing centrifugation with 2000-3000 revolutions per minute (RPM) for 20 minutes. Furthermore, we carried out blood serum tests to check neuropeptide Y levels using the Human Neuropeptide Y Enzyme-link Immunosorbent Assay (ELISA) kit

Healthy groupNon-healthy group

Eligibility Criteria

Age20 Years - 60 Years
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy groups for Neuropeptide Y Serum diagnosis

You may not qualify if:

  • Non-healthy groups for Neuropeptide Y Serum diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine Universitas Sumatera Utara

Medan, North Sumatra, 20155, Indonesia

Location

MeSH Terms

Conditions

ObesityCoitus

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsSexual BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 23, 2020

First Posted

December 2, 2020

Study Start

April 2, 2020

Primary Completion

June 17, 2020

Study Completion

September 10, 2020

Last Updated

December 2, 2020

Record last verified: 2020-11

Locations

ID(1)